<DOC>
	<DOC>NCT00503217</DOC>
	<brief_summary>The aim of this study is to assess whether GnRH agonist administration in the luteal phase improves pregnancy outcome in intrauterine insemination (IUI) cycles.</brief_summary>
	<brief_title>GnRH Agonist and Intrauterine Insemination</brief_title>
	<detailed_description />
	<mesh_term>Deslorelin</mesh_term>
	<criteria>Women &lt; 38 years old Bilateral tubal patency confirmed by hysterosonography Normal ultrasound scan of uterus and ovaries Normal day 3 basal hormones Motile sperm count after capacitation ≥ 3 mill/ml Endometriosis Polycystic ovary syndrome Uterine disease (polyps, myomas and müllerian diseases)</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>intrauterine insemination</keyword>
	<keyword>GnRH agonist</keyword>
	<keyword>implantation</keyword>
</DOC>